New SAE Reporting Policy

Consistent with FDA and OHRP guidance on Adverse Event reporting to IRBs, Sterling IRB no longer requires the submission of Adverse Events unless the event is serious, unexpected, and related or possibly related to participation in the research. This change in policy was effective April 13, 2012. The revised Serious Adverse Event Report form is available in the Investigator Forms section of the Sterling IRB website and may be accessed here.

why-sterling-2

WHY CHOOSE STERLING?

Innovation. Passion. Commitment. We believe these are the essential components of strong teamwork.

review-board-2

REVIEW BOARD

A diverse group of scientific and non-scientific members with nearly a century of collective IRB experience.

research-canada-mexico-2

RESEARCH IN CANADA

Sterling IRB has formed a strategic partnership with Veritas IRB.

©2014 Sterling IRB. All rights reserved.